Agios Pharmaceuticals Inc
LSE:0HB0
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
Agios Pharmaceuticals Inc (0HB0) under the Base Case is USD per share.
Compared with the current market price of 30.56 USD, the stock appears .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 11 months.
Create a free account · No card needed
Fundamental Analysis
What Agios Pharmaceuticals Does
Agios Pharmaceuticals is a biotech company that develops medicines for rare blood disorders. Its main approved drug is Pyrukynd, a pill used to treat certain inherited anemia conditions by helping red blood cells make energy more efficiently. The company also keeps working on other drug candidates in rare hematology, using the same idea of targeting cell metabolism.
- Headquarters
- United States of America US
- Employees
- 539
- IPO date
- Jul 24, 2013
Continue 0HB0 Research
Decided on Agios Pharmaceuticals? Get an email when 0HB0 reaches the price you’d buy at. Free with an account.
Other Agios Pharmaceuticals listings
What is the Intrinsic Value of one 0HB0 stock?
The intrinsic value for
Agios Pharmaceuticals Inc (0HB0) under the Base Case is USD.
Is 0HB0 stock undervalued or overvalued?
Compared with the current market price of 30.56 USD, the stock appears .